Proof of Usefulness Report

Sculpta Inc.

Analysis completed on 3/19/2026

+106.64

Proof of Usefulness Score

Gaining Momentum

While the core concept of RNA-based neurotherapeutics is highly innovative and solves a genuine problem, the submission is severely penalized for blatant inconsistencies and hyperbolic claims. Asserting that 'most people have used my product' is entirely unsupported for a pre-seed biotech startup launched in 2024. As a result, verifiable traction and audience reach metrics received lowest quality factor multipliers.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+50

Audience Reach Impact+1

Technical Innovation+37.5

Evidence Of Traction+1.25

Market Timing Relevance+20

Functional Completeness+2.5

Subtotal+112.25

Usefulness Multiplierx0.95

Final Score+107

Project Details

Project URL

sculpta.bio

Description

Sculpta is a science-first biotech startup developing RNA-based neurotherapeutics to modulate disease-associated biological pathways with higher precision and efficacy. Our CEO is a former Stanford University Assistant Professor and physician-scientist (MD/PhD) with publications in Nature, Cell, Science, etc. Our team includes accomplished scientists with expertise in RNA biology, brain organoids, transcriptomics, and machine learning. Backed by VCs with an oversubscribed pre-seed round in March 2025, we’re building a platform that will drive translational discovery and make a difference in brain health for all.

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline